Navigation Links
Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast
Date:2/22/2008

some. We can't wait to meet the winner."

To support their Breakfast BREAKS awareness campaign, the Jonas Brothers will be involved in events and initiatives taking place throughout the year with updates being posted on http://www.BreakfastBREAKS.com. The website is also the exclusive home for the Breakfast BREAKS Jonas Brothers video initiative and includes information on how to enter the contest. Entries will be accepted beginning March 1, 2008 and kids will be able to regularly check the site to see which videos have been selected to be featured. All viewers will have the chance to rate their favorites. One winning video will be chosen and the winner will join the Jonas Brothers for an appearance in the next Breakfast BREAKS commercial to be aired nationally.

Kevin, Joe and Nick are featured on specially marked Breakfast BREAKS boxes that are currently available in stores. They also shot a commercial and print ad for the product with their parents, Denise and Kevin, Sr., and little brother, Frankie, that will be aired on national television and featured in magazines.

"The Jonas Brothers musical success has made them superstars, so having them partner with Breakfast BREAKS is a great opportunity for us to reach teens across the country with the message that eating breakfast is critical to starting the day right," said Gary A. Davis, CEO, East Side Entrees. "Studies show that children who eat breakfast perform better in school and have overall better health than those who skip morning meals so Breakfast BREAKS was created to serve breakfast quickly and conveniently so that busy families never miss out on a nutritious breakfast everyday."

The retail version of Breakfast BREAKS is sold in a convenient single-serve box that contains a Bowl Pack(TM) cereal from General Mills, a 100% fruit juice box from Minute Maid(R), a division of The Coca-Cola Company, a nutritious snack and utensi
'/>"/>

SOURCE ESE Foods
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Right breakfast bread keeps blood sugar in check all day
2. Sunday, October 14, MSPP holds Sixth Annual Lucero Memorial Run and Latino Leadership Breakfast
3. got breakfast?(TM) Foundation Issues Statement on Recently Released Florida State Plan of Action from the Governors Council on Physical Fitness
4. National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks
5. Ozone Breaks Down Lungs Defenses
6. AHFs Innovative Stay Negative HIV Prevention Campaign Successfully Breaks Through to Target Audience
7. Future MRSA Outbreaks in Schools are Preventable!
8. Californias Pay for Performance Breaks Ground With New Program Components
9. Large avian flu outbreaks more likely to involve duck meat industry, experts find
10. Agencies must win trust of locals to contain Marburg and Ebola outbreaks
11. Infection outbreaks on teeth can cause alopecia areata or localized hair loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...suggests more choices need to be available to coup...s) -- A new survey suggests that many American wom...appy with the usual options available for the disp..., Most of 1,020 women surveyed said they were ver...o be thawed and thrown away, used by other women, ...
(Date:12/4/2008)...ogists have discovered a mechanism that is critica..., where a cell divides into two identical daughter...ow on the assembly and activity of a ring of actin...l at just the right time. They focused on key prot...romote the production of both linear and branching...
(Date:12/4/2008)...GELES, Dec. 4 Jessica Biel and fam...liday party held Dec. 2 at the Childrens,Hospital...ake The Difference,Network, included numerous rec...n an effort to bring holiday spirit to children at...umerous activities as well as seeing some of the,...
(Date:12/4/2008)...GTON, Dec. 4 On this I...gainst Women , the Pan American Health and Educati...s Global Violence Prevention project. The project ...mmunity that violence is preventable. , , ...nce Prevention: The Investment that Saves Lives , ...
Breaking Medicine News(10 mins):Health News:Women Unhappy With Disposal Options After Infertility Treatment 2Health News:Women Unhappy With Disposal Options After Infertility Treatment 3Health News:Researchers gain new insight on wonder of cell division 2Health News:Jessica Biel and Make The Difference Network Bring Holiday Cheer to Childrens Hospital Los Angeles 2Health News:PAHEF Works to Prevent Violence Against Women 2
... debt ridden NHS hospital's radiotherapy departmen...sm from the union and the conservatives//. To eff...in Suffolk, suggestions came in from the staff tha...n Saturdays to put the under utilized equipments t...
... pride of people of the Ottawa region when the cla...Health Centre which offers// psychiatric care and...,000-square-foot facility puts 188 inpatient beds ...ng the first public hospital to be entirely financ...
...scious in Jaipur, flower therapy is becoming the m...ng people enhance their beauty are parlours// and ...cne problems or under eye dark circles, flower the...on. "We get 7 to 10 customers every day," says Ne...
...e on patients to unravel the effect of behavioral...st a couple of sessions of counseling// that focus...to find themselves sleeping well. During sessions...reasons which could cause sleeplessness in individ...
Other Medicine News:Health News:Pet Peeves: Conservatives Howl at Proposal to Share NHS Hosp by Pets and People 2
(Date:12/4/2008)...PRNewswire-FirstCall/ -- Thoratec Corporation,(Na...hanical circulatory support,therapies to save, su...a,pre-specified interim analysis of data from its...ial shows that patients implanted with the device,...hose in the control group who,were implanted with...
(Date:12/4/2008)... to Advance to Clinical Trials , , SAN DIEG... Inc., a biopharmaceutical company focused on the ...gonists for the treatment of cancer, respiratory a...s initiated a Phase I clinical trial of VTX-2337, ...er. The multi-center clinical trial is being cond...
(Date:12/3/2008)...monstrating potential in newly diagnosed patients ...tured in two oral sessions at ASH , , - Exj...y transfused patients by significantly reducing to...ew long-term data from major independent breast ca...ery treatment strategy, Femara vs. tamoxifen , ...
(Date:12/3/2008)...iates long-term anemia and organ damage in mice an... MEMPHIS, Tenn., Dec. 3 ...e into mouse blood cells, scientists at St. Jude C... cell disease pathology. In their studies, the res...ially no difference from normal mice. Although the...
Breaking Medicine Technology:Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 2Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 3Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 4VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform 3091 1AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform 3091 2AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform 3091 3A breakthrough in contrast enhanced intraoperative ultrasonography 26539 1Does probiotic intervention induce the serum global lipid profile change 3F 26535 1Does probiotic intervention induce the serum global lipid profile change 3F 26535 2Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday September 24th 3090 1Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday September 24th 3090 2
..., Switzerland, April 3, 2007 (PRIME NEWSWIRE) -- N...logical and,pharmacokinetic profiles of Basilea,s ...role and isavuconazole. Studies reported,both for ...ephalosporin in late-stage development, and for is...vasive fungal infections,yielded further data on ...
... France, April 04, 2007 /PRNewswire/ -- Novagali P...ny specialized in,ophthalmology, announces today p...of Vekacia(R) in children suffering from Vernal,Ke...it was shown,that both symptoms and signs of disea...hermore, the tolerability to Vekacia(R),was excell...
Other Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2
Performa cemented stem.
Porous foundation 470 series.
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications.
The link classic plus hip stem for cemented primary hip replacement surgery
Medicine Products: